From the race to the COVID-19 cure to the new manufacturing technologies that could be a game changer for stem cell therapies.
With COVID-19 still a significant feature in the drug discovery landscape, this issue looks at the race to finding a cure – from the quest to creating a core model for solving the pandemic crisis, to an exciting collaboration involving scientists from academia and industry looking to identify potential SARS-CoV-2 main protease inhibitors.
Other stories in this summer include high content screening and how this tool can identify novel antivirals and vaccines. We also take an in-depth look at personalised medicine and how to hone in on the perfect target, while our business focus asks whether new manufacturing technologies might make the promise of stem cell therapies a reality
